Response threshold to levodopa in psychiatric patients.
D000328:Adult; D001923:Brain Chemistry / Q000187:drug effects; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004341:Drug Evaluation; D006801:Humans; D007406:Interview, Psychological; D007989:Libido / Q000187:drug effects; D001523:Mental Disorders / Q000188:drug therapy*; D009069:Movement Disorders / Q000139:chemically induced; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy; D012563:Schizophrenia, Paranoid / Q000139:chemically induced; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced
D010919:Placebos; D004295:Dihydroxyphenylalanine; D004298:Dopamine